eadership in Infection Control

Not Applicable

Conditions: prevention of nosocomial infections
Enterocolitis due to Clostridium difficile
R65
A04.7
Systemic Inflammatory Response Syndrome [SIRS]

Registration Number: DRKS00013016

Lead Sponsor: Institut für Hygiene und UmweltmedizinCharité-Universitätsmedizin Berlin

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Enrolling by invitation

Sex: All

Target Recruitment: 29

Inclusion Criteria

Participation of the hospital for at least 18 months in the nosocomial infection surveillance system (KISS) modules hand-KISS, MRSA-KISS (Surveillance of Methicillin-Resistant Staphylococcus aureus) and CDAD-KISS (Surveillance of Clostridium difficile associated diarrhea). Approval of the hospital management to participate. Participation by the Medical Director or his deputy.

Exclusion Criteria

Participation of the hospital in a similar study.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the incidence (cases/ 1000 patients per year) and the incidence-density (cases/1000 patient days per year) of hospital-acquired blood stream infections (HA-BSI) on hospital level for 2017, 2018 and 2019. For this endpoint, blood cultures from day 3 after hospital admission are taken into account. Data are collected by the national nosocomial surveillance System.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints for 2017, 2018 and 2019 are (i) the incidence/ incidence density of HA-BSI with resistant pathogens, (ii) the incidence/ incidence density of hospital-acquired clostridium difficile infections (CDI), and (iii) the consumption of alcohol-based hand rubs. All escondary endpoints are analyzed on hospital Level. Data are collected by the national nosocomial surveillance system.